These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
552 related items for PubMed ID: 9176382
1. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Felgar RE, Macon WR, Kinney MC, Roberts S, Pasha T, Salhany KE. Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382 [Abstract] [Full Text] [Related]
2. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. Kanavaros P, Vlychou M, Stefanaki K, Rontogianni D, Gaulard P, Pantelidaki E, Zois M, Darivianaki K, Georgoulias V, Boulland ML, Gorgoulis V, Kittas C. Anticancer Res; 1999 Jun; 19(2A):1209-16. PubMed ID: 10368677 [Abstract] [Full Text] [Related]
3. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas. Boulland ML, Kanavaros P, Wechsler J, Casiraghi O, Gaulard P. J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260 [Abstract] [Full Text] [Related]
4. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types. Ohshima K, Liu Q, Koga T, Suzumiya J, Kikuchi M. Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825 [Abstract] [Full Text] [Related]
6. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Carbone A, Gloghini A, Gruss HJ, Pinto A. Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367 [Abstract] [Full Text] [Related]
11. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression. Kanavaros P, Boulland ML, Petit B, Arnulf B, Gaulard P. Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738 [Abstract] [Full Text] [Related]
12. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. Nguyen PL, Harris NL, Ritz J, Robertson MJ. Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139 [Abstract] [Full Text] [Related]
13. Epstein-Barr virus is present in neoplastic cytotoxic T cells in extranodal, and predominantly in B cells in nodal T non-Hodgkin lymphomas. Brink AA, ten Berge RL, van den Brule AJ, Willemze R, Chott A, Meijer CJ. J Pathol; 2000 Aug; 191(4):400-6. PubMed ID: 10918215 [Abstract] [Full Text] [Related]
14. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. Rakozy CK, Mohamed AN, Vo TD, Khatib G, Long PM, Eilender D, Palutke M. Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062 [Abstract] [Full Text] [Related]
16. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas. Cotta CV, Leventaki V, Atsaves V, Vidaki A, Schlette E, Jones D, Medeiros LJ, Rassidakis GZ. Cancer; 2008 Feb 01; 112(3):552-61. PubMed ID: 18085637 [Abstract] [Full Text] [Related]
18. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Ko YH, Cho EY, Kim JE, Lee SS, Huh JR, Chang HK, Yang WI, Kim CW, Kim SW, Ree HJ. Histopathology; 2004 May 01; 44(5):480-9. PubMed ID: 15139996 [Abstract] [Full Text] [Related]
19. Fas ligand expression in nodal non-Hodgkin's lymphoma. Müllauer L, Mosberger I, Chott A. Mod Pathol; 1998 Apr 01; 11(4):369-75. PubMed ID: 9578088 [Abstract] [Full Text] [Related]